Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Year-over-year total asset growth rate
5Y CAGR
+31.8%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
4x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 30.77% |
| Q2 2025 | -68.58% |
| Q1 2025 | -47.62% |
| Q4 2024 | -27.58% |
| Q3 2024 | -29.12% |
| Q2 2024 | -19.59% |
| Q1 2024 | -17.60% |
| Q4 2023 | -16.14% |
| Q3 2023 | -19.72% |
| Q2 2023 | -14.81% |
| Q1 2023 | 116.39% |
| Q4 2022 | -17.76% |
| Q3 2022 | -9.88% |
| Q2 2022 | -56.89% |
| Q1 2022 | -27.75% |
| Q4 2021 | 32.64% |
| Q3 2021 | -2.23% |
| Q2 2021 | 29.31% |
| Q1 2021 | -1.08% |
| Q4 2020 | 72.85% |
| Q3 2020 | 7.72% |
| Q2 2020 | -3.30% |
| Q1 2020 | -8.48% |
| Q4 2019 | -4.22% |
| Q3 2019 | -6.44% |
| Q2 2019 | 21.03% |
| Q1 2019 | -5.49% |
| Q4 2018 | -6.48% |
| Q3 2018 | -3.57% |
| Q2 2018 | 54.08% |
| Q1 2018 | 6.92% |
| Q4 2017 | 3.91% |
| Q3 2017 | -23.97% |
| Q2 2017 | -4.06% |
| Q1 2017 | -4.83% |
| Q4 2016 | 30.81% |
| Q3 2016 | 758.72% |
| Q2 2016 | -35.35% |
| Q1 2016 | -61.08% |
| Q4 2015 | -22.64% |